Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2014-04-21

Clinical Trial Update: Negative Pressure Wound Therapy -PREVENA in Prevention of Infections After Total Knee Arthroplasty (TKA) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating PREVENA negative pressure wound therapy to prevent infections after total knee arthroplasty.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Prevena

Snippet

Sponsor: Hadassah Medical Organization | Conditions: Total Knee Replacement | Phase 2 | Status: UNKNOWN